173 related articles for article (PubMed ID: 36109820)
1. A pan-cancer analysis of the oncogenic role of leucine zipper protein 2 in human cancer.
Feng D; Shi X; Zhu W; Zhang F; Li D; Han P; Wei Q; Yang L
Exp Hematol Oncol; 2022 Sep; 11(1):55. PubMed ID: 36109820
[TBL] [Abstract][Full Text] [Related]
2. A pan-cancer analysis of the oncogenic role of zinc finger protein 419 in human cancer.
Zhu W; Feng D; Shi X; Li D; Wei Q; Yang L
Front Oncol; 2022; 12():1042118. PubMed ID: 36578929
[TBL] [Abstract][Full Text] [Related]
3. Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective.
Khan M; Ai M; Du K; Song J; Wang B; Lin J; Ren A; Chen C; Huang Z; Qiu W; Zhang J; Tian Y; Yuan Y
Front Immunol; 2022; 13():1062225. PubMed ID: 36605187
[TBL] [Abstract][Full Text] [Related]
4. A pan-cancer analysis of the oncogenic and immunological roles of apolipoprotein F (APOF) in human cancer.
Shi X; Feng D; Li D; Han P; Yang L; Wei W
Eur J Med Res; 2023 Jun; 28(1):190. PubMed ID: 37312170
[TBL] [Abstract][Full Text] [Related]
5. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
6. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of LUZP2 Is Correlated with Poor Prognosis of Low-Grade Glioma.
Li Y; Deng G; Qi Y; Zhang H; Jiang H; Geng R; Ye Z; Liu B; Chen Q
Biomed Res Int; 2020; 2020():9716720. PubMed ID: 32695826
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of tumor necrosis factor-α-inducible protein 8-like 2 (TIPE2): A potential novel pan-cancer immune checkpoint.
Bai KH; Zhang YY; Li XP; Tian XP; Pan MM; Wang DW; Dai YJ
Comput Struct Biotechnol J; 2022; 20():5226-5234. PubMed ID: 36187930
[TBL] [Abstract][Full Text] [Related]
9. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
10. Leucine zipper protein 2 serves as a prognostic biomarker for prostate cancer correlating with immune infiltration and epigenetic regulation.
Feng D; Zhu W; Shi X; Wei W; Han P; Wei Q; Yang L
Heliyon; 2022 Oct; 8(10):e10750. PubMed ID: 36217461
[TBL] [Abstract][Full Text] [Related]
11. Carbonic Anhydrase 4 serves as a Clinicopathological Biomarker for Outcomes and Immune Infiltration in Renal Cell Carcinoma, Lower Grade Glioma, Lung Adenocarcinoma and Uveal Melanoma.
Xu Y; Xu WH; Shi SN; Yang XL; Ren YR; Zhuang XY; Qu YY; Zhang HL; Zhang XF
J Cancer; 2020; 11(20):6101-6113. PubMed ID: 32922550
[No Abstract] [Full Text] [Related]
12. Bioinformatics and survival analysis of glia maturation factor-γ in pan-cancers.
Lan A; Ren C; Wang X; Tong G; Yang G
BMC Cancer; 2021 Apr; 21(1):423. PubMed ID: 33863293
[TBL] [Abstract][Full Text] [Related]
13. Significance of Chr9p22.1-p21.3 Deletion in Cancer Development: A Pan-cancer
Gonçalves PG; Reis RM; Bidinotto LT
Anticancer Res; 2022 Nov; 42(11):5291-5304. PubMed ID: 36288884
[TBL] [Abstract][Full Text] [Related]
14. The molecular feature of macrophages in tumor immune microenvironment of glioma patients.
Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z
Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502
[TBL] [Abstract][Full Text] [Related]
15. NFE2L2 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltration in Brain Lower Grade Glioma: A Pan-Cancer Analysis.
Ju Q; Li X; Zhang H; Yan S; Li Y; Zhao Y
Oxid Med Cell Longev; 2020; 2020():3580719. PubMed ID: 33101586
[TBL] [Abstract][Full Text] [Related]
16. Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer Types.
Wu Y; Huang W; Xie Y; Wang C; Luo N; Chen Y; Wang L; Cheng Z; Gao Z; Liu S
Front Mol Biosci; 2022; 9():743515. PubMed ID: 35372497
[TBL] [Abstract][Full Text] [Related]
17. Violations of proportional hazard assumption in Cox regression model of transcriptomic data in TCGA pan-cancer cohorts.
Zeng Z; Gao Y; Li J; Zhang G; Sun S; Wu Q; Gong Y; Xie C
Comput Struct Biotechnol J; 2022; 20():496-507. PubMed ID: 35070171
[TBL] [Abstract][Full Text] [Related]
18. Pan-Cancer Analysis Revealed
Liu J; Wang Y; Yin J; Yang Y; Geng R; Zhong Z; Ni S; Liu W; Du M; Yu H; Bai J
J Oncol; 2022; 2022():3477148. PubMed ID: 35069733
[TBL] [Abstract][Full Text] [Related]
19. Integrative omics analysis reveals relationships of genes with synthetic lethal interactions through a pan-cancer analysis.
Guo L; Li S; Qian B; Wang Y; Duan R; Jiang W; Kang Y; Dou Y; Yang G; Shen L; Wang J; Liang T
Comput Struct Biotechnol J; 2020; 18():3243-3254. PubMed ID: 33240468
[TBL] [Abstract][Full Text] [Related]
20. The Landscape of Whole-genome Alterations and Pathologic Features in Genitourinary Malignancies: An Analysis of the Cancer Genome Atlas.
Ball MW; Gorin MA; Drake CG; Hammers HJ; Allaf ME
Eur Urol Focus; 2017 Dec; 3(6):584-589. PubMed ID: 28753846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]